Attitudes Toward and Use of Cancer Management Guidelines in a National Sample of Medical Oncologists and Surgeons

被引:17
|
作者
Jagsi, Reshma [1 ]
Huang, Grace [2 ]
Griffith, Kent [3 ]
Zikmund-Fisher, Brian J. [4 ]
Janz, Nancy K. [4 ]
Griggs, Jennifer J. [5 ]
Katz, Steven J. [6 ]
Hawley, Sarah T. [6 ]
机构
[1] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Dept Hlth Behav & Hlth Educ, Ann Arbor, MI 48109 USA
[5] Univ Michigan, Div Hematol & Oncol, Ann Arbor, MI 48109 USA
[6] Univ Michigan, Div Gen Med, Ann Arbor, MI 48109 USA
关键词
CLINICAL-PRACTICE GUIDELINES; DISPARITIES; ADHERENCE; THERAPY; TRENDS; CARE;
D O I
10.6004/jnccn.2014.0021
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Physician attitudes toward and lack of familiarity with guidelines have been identified as potential barriers to adherence in general, but little is known about their attitudes toward and use of cancer management guidelines specifically. This study surveyed 1500 surgeons and medical oncologists drawn from the AMA Masterfile in 2012. This report describes and compares the attitudes of medical oncologists and surgeons who treat patients with breast cancer regarding guidelines in general and the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) in particular, and their familiarity, use, and compliance with these guidelines. Of 896 respondents, responses were analyzed from the 766 who had seen at least one new patient with breast cancer in the past year. Mean participant age was 52 years; 25% worked in a teaching setting. Attitudes toward guidelines were generally favorable. Medical oncologists were more likely than surgeons to be aware that NCCN issues guidelines for cancer management (100% vs 74%; P < .001) and more likely to state that these guidelines generally influence their decisions (96% vs 70%; P < .001). Among those aware of NCCN Guidelines, 96% reported that they often agreed with NCCN recommendations, and 75% reported that almost all of their breast cancer treatment recommendations were consistent with these guidelines. Still, most providers (77%) also reported that they refer one-fourth or fewer of their patients with breast cancer to the NCCN Guidelines for Patients. Attitudes toward physician-directed cancer management guidelines are generally positive, and they are frequently used. However, existing guidelines seem to have greater visibility to the medical oncology audience than to surgeons, and patient versions are infrequently recommended.
引用
收藏
页码:204 / 212
页数:9
相关论文
共 50 条
  • [41] A national survey on the management of liver metastases from colorectal cancer (CRC): Comparison of perspectives and expectations among medical oncologists and hepatobiliary surgeons across Canada.
    Ho, Maria Yi
    Cleary, Sean P.
    Mazurek, Matthew
    Ghosh, Sunita
    Cheung, Winson Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [42] A National Survey of Breast Surgeons and Radiation Oncologists on Contemporary Axillary Management in Mastectomy Patients
    Cortina, Chandler S.
    Bergom, Carmen
    Craft, Morgan Ashley
    Fields, British
    Brazauskas, Ruta
    Currey, Adam
    Kong, Amanda L.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (10) : 5568 - 5579
  • [43] A National Survey of Breast Surgeons and Radiation Oncologists on Contemporary Axillary Management in Mastectomy Patients
    Chandler S. Cortina
    Carmen Bergom
    Morgan Ashley Craft
    British Fields
    Ruta Brazauskas
    Adam Currey
    Amanda L. Kong
    Annals of Surgical Oncology, 2021, 28 : 5568 - 5579
  • [44] Medical Students' perceptions and attitudes toward Medical Leadership and Management
    Alzahrani, Sami Hamdan
    Baig, Mukhtiar
    Omer, Anoud R.
    Algethami, Mohammed R.
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2021, 37 (01) : 223 - 228
  • [45] Principles and guidelines for surgeons - Management of symptomatic breast cancer
    BlichertToft, M
    Smola, MG
    Cataliotti, L
    OHiggins, N
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1997, 23 (02): : 101 - 109
  • [46] Controversies in the management of rectal cancer. A survey of French surgeons, oncologists and radiotherapists
    Lefevre, J. H.
    Benoist, S.
    COLORECTAL DISEASE, 2016, 18 (02) : 128 - 134
  • [47] MEDICAL-STUDENTS ATTITUDES TOWARD CANCER
    COOPER, S
    BEAN, G
    ALPERT, R
    BAUM, JH
    JOURNAL OF MEDICAL EDUCATION, 1980, 55 (05): : 434 - 439
  • [48] Utility and Actual Use of European and Spanish Guidelines on the Management of Endometrial Cancer Among Gynecologic Oncologists in Spain
    Zapardiel, Ignacio
    Blancafort, Claudia
    Cibula, David
    Jaunarena, Ibon
    Gorostidi, Mikel
    Gil-Moreno, Antonio
    De Santiago, Javier
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 (06) : 1293 - 1297
  • [49] Clinical practice guidelines for the management of metastatic colorectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO)
    Dervenis, Christos
    Xynos, Evaghelos
    Sotiropoulos, George
    Gouvas, Nikolaos
    Boukovinas, Ioannis
    Agalianos, Christos
    Androulakis, Nikolaos
    Athanasiadis, Athanasios
    Christodoulou, Christos
    Chrysou, Evangelia
    Emmanouilidis, Christos
    Georgiou, Panagiotis
    Karachaliou, Niki
    Katopodi, Ourania
    Kountourakis, Panteleimon
    Kyriazanos, Ioannis
    Makatsoris, Thomas
    Papakostas, Pavlos
    Papamichael, Demetris
    Pechlivanides, George
    Pentheroudakis, Georgios
    Pilpilidis, Ioannis
    Sgouros, Joseph
    Tekkis, Paris
    Triantopoulou, Charina
    Tzardi, Maria
    Vassiliou, Vassilis
    Vini, Louiza
    Xynogalos, Spyridon
    Zirasz, Nikolaos
    Souglakos, John
    ANNALS OF GASTROENTEROLOGY, 2016, 29 (04): : 390 - 416
  • [50] National Survey of US Oncologists' Knowledge, Attitudes, and Practice Patterns Regarding Herb and Supplement Use by Patients With Cancer
    Lee, Richard T.
    Barbo, Andrea
    Lopez, Gabriel
    Melhem-Bertrandt, Amal
    Lin, Heather
    Olopade, Olufunmilayo I.
    Curlin, Farr A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (36) : 4095 - U314